News

 Lisa Zickuhr, MD, MHPE from the Washington University School of Medicine Division of Rheumatology joined Irene Blanco, MD, MS from Albert Einstein School of Medicine Division of Rheumatology and Lisa Criscione-Schieber, MD, Med from Duke University School of Medicine Division of Rheumatology in the presentation, “How to Incorporate DEI into Your Fellows Program Curriculum,” at […]

In collaboration with Frank O’Brien, MD from the Division of Nephrology and Nathaniel Nolan, MD, MPH from the Division of Infectious Diseases, Andrew Robinson, MSW LMSW and Lisa Zickuhr, MD, MHPE from the Division of Rheumatology presented a workshop titled, “Interprofessional, Multidisciplinary Case Conference:  A Novel Approach to Integrating Health Equity into Graduate Medical Education,” […]

Lisa Zickuhr, MD, MHPE from the Washington University School of Medicine Division of Rheumatology and Sarah Goglin, MD from the University of California – San Francisco Division of Rheumatology delivered a Teaching Pearl Presentation at the American College of Rheumatology’s Education Exchange 2022 in Orlando, FL.  Drs. Zickuhr and Goglin partnered with eight educators from […]

We are extremely pleased to announce that Dr. Lenschow was appointed the John S Daniels Professor in Immunology. The professorship was made possible by a gift from Noémi and Michael Neidorff and established in honor of Dr. John Daniels, a Washington University associate professor of clinical medicine who specializes in endocrinology and metabolism and in […]

They will conduct a workshop about integrating Health Equity into fellowship training curricula, reviewing best practices and sharing their experiences from their own interprofessional and multidisciplinary case conference. Check them out if you are attending AIMW22! 

COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.

Congratulations Lisa for receiving the 2021 inagugural Academy of Educators Rising Star Award!

Dr. Can Sungur received the Knowlton Incentive for Excellence Award

Al Kim, MD, PhD, launched the COVaRiPAD study, a multi-departmental effort (Medicine, Neurology, Molecular Microbiology, Pathology & Immunology, Genetics) to examine COVID-19 vaccine responses in patients with autoimmune diseases

Michael A. Paley, MD, PhD, has been awarded a grant from Arthritis National Research Foundation for his project: Mechanistic Insights into Organ-Specific Manifestations of Spondyloarthritis

Lisa Zickuhr MD, Colin Diffie MD, and Amber Deptola MD, in collaboration with John Metzler MD and Nathan Olafsen MD, received a Small Projects Grant from Washington University’s Medical Education Research Unit. The grant supports a multi-disciplinary group of internists, physiatrists, and rheumatologists to develop and gather validity evidence for a tool that assesses the performance […]

Funding for Pilot and Feasibility Studies Related to the Rheumatic Diseases February 2021 The Rheumatic Diseases Research Resource-based Center (RDRRC) at Washington University is pleased to announce the availability of research funds for its Pilot and Feasibility (P/F) program. The overall goal of this program is to help develop innovative research programs at their earliest […]

Al Kim, MD, PhD launched the COVaRiPAD study, a multi-departmental effort (Medicine, Neurology, Molecular Microbiology, Pathology & Immunology, Genetics) to examine COVID-19 vaccine responses in patients with autoimmune diseases

Dr. Lisa Zickuhr was appointed the Associate Clerkship Director for Internal Medicine. Dr. Zickuhr is also the 2021 recipient of the Rheumatology Research Foundation Clinician Scholar Educator Award, which proposes to design and evaluate a telerheumatology curriculum. Dr. Deborah Lenschow was named Co-Director of the Immunology Graduate Program. Dr. Lenschow also received the 2020 ICTS/FBJH […]

The Department of Medicine is very happy to welcome our new Associate Clerkship Director for Internal Medicine, Dr. Lisa Zickuhr. She will be assisting the current clerkship director Dr. Gerome Escota in providing professional, administrative, and educational leadership for third and fourth year students rotating in Medicine. Dr. Zickuhr is an Assistant Professor of Medicine […]

Dear Colleagues, We are pleased to announce that the Washington University Rheumatic Diseases Research Resource-based Center (WU-RDRRC) is up and running. The mission of the WU-RDRRC is to advance research in rheumatic diseases by providing the infrastructure, education, and training to assist our members in the experimental and scientific design of their projects. We provide […]

When Kim Morey was a young girl, a mysterious illness affected her family, striking relatives one by one at around the age of 40, she recalled.

Masters of the American College of Rheumatology 2018 This is one of the highest honors the College bestows to members who have made outstanding contributions to the field of rheumatology through scholarly achievement and/or service to their patients, students, and profession. Other Masters in our Division include Dr. John Atkinson, MD and Dr. Benjamin Schwartz, MD PhD

Patients in south St. Louis County and southern Illinois will soon have access to a higher level of care closer to home. The Center for Advanced Medicine – South County is opening April 19. The new outpatient facility jointly owned by Barnes-Jewish and Washington University is located near the Siteman Cancer Center at I-55 and […]

Clayco’s chairman and CEO, Robert G. Clark, along with the company’s partners, have committed $4.1 million to Washington University School of Medicine in St. Louis to advance research into a rare blood vessel disease that results in death five to 10 years following diagnosis.